The DOI matches its Crossref record; 63 of the 64 references it cites were found in a registry or an index.
A role for mitochondrial enzymes in inherited neoplasia and beyond
Abstract
Mitochondrial defects have been associated with neurological disorders, as well as cancers. Two ubiquitously expressed mitochondrial enzymes--succinate dehydrogenase (SDH) and fumarate hydratase (FH, fumarase)--catalyse sequential steps in the Krebs tricarboxylic-acid cycle. Inherited heterozygous mutations in the genes encoding these enzymes cause predispositions to two types of inherited neoplasia syndromes that do not share any component tumours. Homozygous mutations in the same genes result in severe neurological impairment. Understanding this link between inherited cancer syndromes and neurological disease could provide further insights into the mechanisms by which mitochondrial deficiencies lead to tumour development.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“We additionally screened constitutional DNA from the 19 patients with fixed, archival paragangliomas or phaeochromocytomas and we found several mutations previously reported in the literature in both SDHB (five paragangliomas and four phaeochromocytomas) and SDHD (four paragangliomas) (16).”
From Accumulation of Krebs cycle intermediates and over-expression of HIF1α in tumours which result from germline FH and SDH mutations (2005) · cites this paper as [16]
Citations
Cites
Green, D. R., & Reed, J. C. (1998) · Science · doi:10.1126/science.281.5381.1309 · Cited by 8,965
Identification of the von Hippel-Lindau Disease Tumor Suppressor Gene
Latif, F., Tory, K., Gnarra, J., Yao, M., Duh, F.-M., Orcutt, M. L., Stackhouse, T., Kuzmin, I., Modi, W., Geil, L., et al. (1993) · Science · doi:10.1126/science.8493574 · Cited by 2,973
Mitochondrial reactive oxygen species trigger hypoxia-induced transcription
Chandel, N. S., Maltepe, E., Goldwasser, E., Mathieu, C. E., Simon, M. C., & Schumacker, P. T. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.20.11715 · Cited by 1,926 · cited 1×
“HIF-1 activates the transcription of genes encoding vascular endothelial growth factor (VEGF) and glycolytic enzyme”
BackgroundMutations in SDHD , a Mitochondrial Complex II Gene, in Hereditary Paraganglioma
Baysal, B. E., Ferrell, R. E., Willett-Brozick, J. E., Lawrence, E. C., Myssiorek, D., Bosch, A., Mey, A. V. D., Taschner, P. E. M., Rubinstein, W. S., Myers, E. N., et al. (2000) · Science · doi:10.1126/science.287.5454.848 · Cited by 1,638
The Multiple Leiomyoma Consortium (2002) · Nature Genetics · doi:10.1038/ng849 · Cited by 1,635
Self-citationGerm-Line Mutations in Nonsyndromic Pheochromocytoma
Neumann, H. P. H., Bausch, B., McWhinney, S. R., Bender, B. U., Gimm, O., Franke, G., Schipper, J., Klisch, J., Altehoefer, C., Zerres, K., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020152 · Cited by 1,367
Self-citationAstuti, D., Latif, F., Dallol, A., Dahia, P. L. M., Douglas, F., George, E., Sköldberg, F., Husebye, E. S., Eng, C., & Maher, E. R. (2001) · The American Journal of Human Genetics · doi:10.1086/321282 · Cited by 1,087
Self-citationMutations in SDHC cause autosomal dominant paraganglioma, type 3
Niemann, S., & Müller, U. (2000) · Nature Genetics · doi:10.1038/81551 · Cited by 875
Somatic mutations of the mitochondrial genome in human colorectal tumours
Polyak, K., Li, Y., Zhu, H., Lengauer, C., Willson, J. K. V., Markowitz, S. D., Trush, M. A., Kinzler, K. W., & Vogelstein, B. (1998) · Nature Genetics · doi:10.1038/3108 · Cited by 835
Eng, C. (1996) · JAMA · doi:10.1001/jama.1996.03540190047028 · Cited by 821
Self-citation
Research works printed but not linked: 3
- Gimm, O., Armanios, M., Dziema, H., Neumann, H. P. H. & Eng, C. Somatic and occult germline mutations in SDHD, a mitochondrial complex II gene, in non-familial pheochromocytomas. Cancer Res. 60, 6822?6825 (2000).
- Triepels, R. H., van den Heuvel, L. & Loeffen, J. Leigh syndrome associated with a mutation in the NDUFS7 (PSST) nuclear encoded subunit of complex I. Ann. Neurol. 45, 787?790 (1999). · DOI · Paper page
- Loeffen, J. et al. Mutations in the complex I NDUFS2 gene of patients with cardiomyopathy and encphalomyopathy. Am. J. Hum. Genet. 49, 195?201 (2001).
Cited by
Cancer genes and the pathways they control
Vogelstein, B., & Kinzler, K. W. (2004) · Nature Medicine · doi:10.1038/nm1087 · Cited by 4,249
Metabolic Reprogramming: A Cancer Hallmark Even Warburg Did Not Anticipate
Ward, P. S., & Thompson, C. B. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.02.014 · Cited by 3,233
Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-α prolyl hydroxylase
Selak, M. A., Armour, S. M., MacKenzie, E. D., Boulahbel, H., Watson, D. G., Mansfield, K. D., Pan, Y., Simon, M. C., Thompson, C. B., & Gottlieb, E. (2005) · Cancer Cell · doi:10.1016/j.ccr.2004.11.022 · Cited by 2,108
“…ubiquitin ligase SDH genes are associated with the development of pheochro-complex that binds to the oxygen-dependent degradation mocytoma and paraganglioma (Baysal, 2003; Eng et al., 2003; (ODD) domain of HIF-(cid:1) in an oxygen-dependent manner and Pollard et al., 2003; Rustin and Rotig, 2002).”
BackgroundThe emerging role of the Nrf2–Keap1 signaling pathway in cancer
Jaramillo, M. C., & Zhang, D. D. (2013) · Genes & Development · doi:10.1101/gad.225680.113 · Cited by 1,297
Assessment of mitochondrial respiratory chain enzymatic activities on tissues and cultured cells
Spinazzi, M., Casarin, A., Pertegato, V., Salviati, L., & Angelini, C. (2012) · Nature Protocols · doi:10.1038/nprot.2012.058 · Cited by 983
Isaacs, J. S., Jung, Y. J., Mole, D. R., Lee, S., Torres-Cabala, C., Chung, Y.-L., Merino, M., Trepel, J., Zbar, B., Toro, J., et al. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.06.017 · Cited by 958
“Thus, the pronounced neurological defects associated with biallelic germline FH deficiency can be explained by the high energy demands of the developing nervous system during embryogenesis coupled with the dependence of neurons upon oxidative phosphorylation (Eng et al., 2003; Shulman et al., 2004).”
BackgroundRole of VHL Gene Mutation in Human Cancer
Kim, W. Y., & Kaelin, W. G. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.05.061 · Cited by 943
Citric acid cycle intermediates as ligands for orphan G-protein-coupled receptors
He, W., Miao, F. J.-P., Lin, D. C.-H., Schwandner, R. T., Wang, Z., Gao, J., Chen, J.-L., Tian, H., & Ling, L. (2004) · Nature · doi:10.1038/nature02488 · Cited by 909
Neumann, H. P. H. (2004) · JAMA · doi:10.1001/jama.292.8.943 · Cited by 893
“Carriers with malignant tumors 11 34 (19-53) 0 0 (0-10) .”
InfluentialPollard, P. J., Brière, J. J., Alam, N. A., Barwell, J., Barclay, E., Wortham, N. C., Hunt, T., Mitchell, M., Olpin, S., Moat, S. J., et al. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi227 · Cited by 865
Analysis of mitochondrial function in situ in permeabilized muscle fibers, tissues and cells
Kuznetsov, A. V., Veksler, V., Gellerich, F. N., Saks, V., Margreiter, R., & Kunz, W. S. (2008) · Nature Protocols · doi:10.1038/nprot.2008.61 · Cited by 801
Succinate dehydrogenase and fumarate hydratase: linking mitochondrial dysfunction and cancer
King, A., Selak, M. A., & Gottlieb, E. (2006) · Oncogene · doi:10.1038/sj.onc.1209594 · Cited by 672
The Dual Roles of NRF2 in Cancer
Menegon, S., Columbano, A., & Giordano, S. (2016) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2016.05.002 · Cited by 633
Hypoxia and mitochondrial oxidative metabolism
Solaini, G., Baracca, A., Lenaz, G., & Sgarbi, G. (2010) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2010.02.011 · Cited by 608
Mitochondrial tumour suppressors: a genetic and biochemical update
Gottlieb, E., & Tomlinson, I. P. M. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1737 · Cited by 621
The emerging role and targetability of the TCA cycle in cancer metabolism
Anderson, N. M., Mucka, P., Kern, J. G., & Feng, H. (2018) · Protein & Cell · doi:10.1007/s13238-017-0451-1 · Cited by 556
Shaw, R. J. (2006) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2006.10.005 · Cited by 550
Inhibition of Hypoxia-inducible Factor (HIF) Hydroxylases by Citric Acid Cycle Intermediates
Koivunen, P., Hirsilä, M., Remes, A. M., Hassinen, I. E., Kivirikko, K. I., & Myllyharju, J. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m610415200 · Cited by 521
The Ventilatory Response to Hypoxia in Mammals: Mechanisms, Measurement, and Analysis
Teppema, L. J., & Dahan, A. (2010) · Physiological Reviews · doi:10.1152/physrev.00012.2009 · Cited by 381
Vanharanta, S., Buchta, M., McWhinney, S. R., Virta, S. K., Peçzkowska, M., Morrison, C. D., Lehtonen, R., Januszewicz, A., Järvinen, H., Juhola, M., et al. (2004) · The American Journal of Human Genetics · doi:10.1086/381054 · Cited by 389
“It is interesting that germline mutations in genes encoding two other subunits of SDH (mitochondrial complex II), SDHB (MIM 185470 and MIM 605373) and SDHC (MIM 602413), were found to be associated with heritable pheochromocytoma and/or PGL (Maher and Eng 2002; Eng et al. 2003).”
BackgroundResultInfluentialSelf-citationMetabolic reprogramming in cancer: Unraveling the role of glutamine in tumorigenesis
Daye, D., & Wellen, K. E. (2012) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2012.02.002 · Cited by 374
Signalling hypoxia by HIF hydroxylases
Schofield, C. J., & Ratcliffe, P. J. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.08.111 · Cited by 341
Chen, J.-Q., & Russo, J. (2012) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2012.06.004 · Cited by 327
Pan, Y., Mansfield, K. D., Bertozzi, C. C., Rudenko, V., Chan, D. A., Giaccia, A. J., & Simon, M. C. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.01223-06 · Cited by 332
Schiavi, F. (2005) · JAMA · doi:10.1001/jama.294.16.2057 · Cited by 329
PHD2 Mutation and Congenital Erythrocytosis with Paraganglioma
Ladroue, C., Carcenac, R., Leporrier, M., Gad, S., Le Hello, C., Galateau-Salle, F., Feunteun, J., Pouysségur, J., Richard, S., & Gardie, B. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0806277 · Cited by 323
Gasparre, G., Porcelli, A. M., Bonora, E., Pennisi, L. F., Toller, M., Iommarini, L., Ghelli, A., Moretti, M., Betts, C. M., Martinelli, G. N., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0703056104 · Cited by 316
Shidara, Y., Yamagata, K., Kanamori, T., Nakano, K., Kwong, J. Q., Manfredi, G., Oda, H., & Ohta, S. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-2012 · Cited by 286
Gill, A. J., Benn, D. E., Chou, A., Clarkson, A., Muljono, A., Meyer-Rochow, G. Y., Richardson, A. L., Sidhu, S. B., Robinson, B. G., & Clifton-Bligh, R. J. (2010) · Human Pathology · doi:10.1016/j.humpath.2009.12.005 · Cited by 277
Mitochondria Targeting as an Effective Strategy for Cancer Therapy
Ghosh, P., Vidal, C., Dey, S., & Zhang, L. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21093363 · Cited by 263
Pathania, D., Millard, M., & Neamati, N. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.05.010 · Cited by 263
Smeitink, J. A., Zeviani, M., Turnbull, D. M., & Jacobs, H. T. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2005.12.001 · Cited by 245
Cancer phenomics: RET and PTEN as illustrative models
Zbuk, K. M., & Eng, C. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2037 · Cited by 239
Self-citationGrasso, D., Zampieri, L. X., Capelôa, T., Van de Velde, J. A., & Sonveaux, P. (2020) · Cell Stress · doi:10.15698/cst2020.06.221 · Cited by 227
Cellular oxygen sensing need in CNS function: physiological and pathological implications
Acker, T., & Acker, H. (2004) · Journal of Experimental Biology · doi:10.1242/jeb.01075 · Cited by 231
Oxidative phosphorylation in cancer cells
Solaini, G., Sgarbi, G., & Baracca, A. (2011) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2010.09.003 · Cited by 231
Bonora, E., Porcelli, A. M., Gasparre, G., Biondi, A., Ghelli, A., Carelli, V., Baracca, A., Tallini, G., Martinuzzi, A., Lenaz, G., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0171 · Cited by 225
Transition metal catalysis in the mitochondria of living cells
Tomás-Gamasa, M., Martínez-Calvo, M., Couceiro, J. R., & Mascareñas, J. L. (2016) · Nature Communications · doi:10.1038/ncomms12538 · Cited by 220
Ni, Y., Zbuk, K. M., Sadler, T., Patocs, A., Lobo, G., Edelman, E., Platzer, P., Orloff, M. S., Waite, K. A., & Eng, C. (2008) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2008.07.011 · Cited by 222
Self-citationSearching for the hereditary causes of renal-cell carcinoma
Pavlovich, C. P., & Schmidt, L. S. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1364 · Cited by 209
Cancer as a mitochondrial metabolic disease
Seyfried, T. N. (2015) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2015.00043 · Cited by 198
Dong, L.-F., Jameson, V. J. A., Tilly, D., Cerny, J., Mahdavian, E., Marín-Hernández, A., Hernández-Esquivel, L., Rodríguez-Enríquez, S., Stursa, J., Witting, P. K., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.186643 · Cited by 200
Mechanisms of mitochondrial diseases
Ylikallio, E., & Suomalainen, A. (2012) · Annals of Medicine · doi:10.3109/07853890.2011.598547 · Cited by 185
Renal Tumors Associated With Germline SDHB Mutation Show Distinctive Morphology
Gill, A. J., Pachter, N. S., Chou, A., Young, B., Clarkson, A., Tucker, K. M., Winship, I. M., Earls, P., Benn, D. E., Robinson, B. G., et al. (2011) · American Journal of Surgical Pathology · doi:10.1097/pas.0b013e318227e7f4 · Cited by 191
Lehtonen, R., Kiuru, M., Vanharanta, S., Sjöberg, J., Aaltonen, L.-M., Aittomäki, K., Arola, J., Butzow, R., Eng, C., Husgafvel-Pursiainen, K., et al. (2004) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63091-x · Cited by 181
Self-citationSuccinate inhibition of α-ketoglutarate-dependent enzymes in a yeast model of paraganglioma
Smith, E. H., Janknecht, R., & Maher, L. J. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm275 · Cited by 169
“ROS have been proposed to play a role in cellular transformation by tumorigenic mutagenesis (29,38,39).”
BackgroundState of the Science: An Update on Renal Cell Carcinoma
Jonasch, E., Futreal, P. A., Davis, I. J., Bailey, S. T., Kim, W. Y., Brugarolas, J., Giaccia, A. J., Kurban, G., Pause, A., Frydman, J., et al. (2012) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-12-0117 · Cited by 162
Bihaqi, S. W., Huang, H., Wu, J., & Zawia, N. H. (2011) · Journal of Alzheimer’s Disease · doi:10.3233/jad-2011-111013 · Cited by 162
The TCA cycle and tumorigenesis: the examples of fumarate hydratase and succinate dehydrogenase
Pollard, P., Wortham, N., & Tomlinson, I. (2003) · Annals of Medicine · doi:10.1080/07853890310018458 · Cited by 159
Hensen, E. F., Jordanova, E. S., van Minderhout, I. J. H. M., Hogendoorn, P. C. W., Taschner, P. E. M., van der Mey, A. G. L., Devilee, P., & Cornelisse, C. J. (2004) · Oncogene · doi:10.1038/sj.onc.1207591 · Cited by 169
Mitochondrial chaperones in cancer: From molecular biology to clinical diagnostics
Czarnecka, A. M., Campanella, C., Zummo, G., & Cappello, F. (2006) · Cancer Biology & Therapy · doi:10.4161/cbt.5.7.2975 · Cited by 152
The metabolic basis of kidney cancer
Linehan, W. M., & Ricketts, C. J. (2012) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2012.06.002 · Cited by 181
Demir, İ. E., Ceyhan, G. O., & Friess, H. (2012) · Digestive Surgery · doi:10.1159/000338086 · Cited by 155
Thangaraju, M., Carswell, K. N., Prasad, P. D., & Ganapathy, V. (2008) · Biochemical Journal · doi:10.1042/bj20081132 · Cited by 152
Effects of hypoxia on tumor metabolism
Kim, J., Gao, P., & Dang, C. V. (2007) · Cancer and Metastasis Reviews · doi:10.1007/s10555-007-9060-4 · Cited by 166
Salminen, A., Kauppinen, A., Hiltunen, M. O., & Kaarniranta, K. (2014) · Ageing Research Reviews · doi:10.1016/j.arr.2014.05.004 · Cited by 148
Electron microscopy morphology of the mitochondrial network in human cancer
Arismendi-Morillo, G. (2009) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2009.02.002 · Cited by 142
Tsirlin, A., Oo, Y. H., Sharma, R., Kansara, A., Gliwa, A., & Banerji, M. (2014) · Maturitas · doi:10.1016/j.maturitas.2013.12.009 · Cited by 154
GW112, A Novel Antiapoptotic Protein That Promotes Tumor Growth
Zhang, X., Huang, Q., Yang, Z., Li, Y., & Li, C. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3443 · Cited by 138
Jiménez, C., Cote, G. J., Arnold, A., & Gagel, R. F. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2178 · Cited by 146
Tumor cell energy metabolism and its common features with yeast metabolism
Díaz-Ruiz, R., Uribe‐Carvajal, S., Devin, A., & Rigoulet, M. (2009) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2009.07.003 · Cited by 155
Dahan, A., Nieuwenhuijs, D. J. F., & Teppema, L. J. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040239 · Cited by 139
Head and Neck Paragangliomas in Von Hippel-Lindau Disease and Multiple Endocrine Neoplasia Type 2
Boedeker, C. C., Erlic, Z., Richard, S., Kontny, U., Gimenez‐Roqueplo, A., Cascón, A., Robledo, M., de Campos, J. M., van Nederveen, F. H., de Krijger, R. R., et al. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0354 · Cited by 138
Self-citationLinehan, W. M., & Zbar, B. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.09.006 · Cited by 129
Pyroptosis in the Initiation and Progression of Atherosclerosis
Qian, Z., Zhao, Y., Wan, C., Deng, Y., Zhuang, Y., Xu, Y., Zhu, Y., Lu, S., & Bao, Z. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.652963 · Cited by 128
Dong, L., Freeman, R., Liu, J., Zobalová, R., Marín‐Hernández, Á., Stantic, M., Rohlena, J., Vališ, K., Rodríguez‐Enríquez, S., Butcher, B., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-2439 · Cited by 138
Ortega, A. D., Sánchez‐Aragó, M., Giner, D., Sánchez-Cenizo, L., Willers, I. M., & Cuezva, J. M. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.08.007 · Cited by 141
von Hippel-Lindau Tumor Suppressor Protein and Hypoxia-Inducible Factor in Kidney Cancer
Maynard, M. A., & Ohh, M. (2003) · American Journal of Nephrology · doi:10.1159/000075346 · Cited by 142
Alterations of metabolic genes and metabolites in cancer
Oermann, E. K., Wu, J., Guan, K., & Xiong, Y. (2012) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2012.01.013 · Cited by 139
Karakelides, H., Asmann, Y. W., Bigelow, M. L., Short, K. R., Dhatariya, K., Coenen-Schimke, J., Kahl, J., Mukhopadhyay, D., & Nair, K. S. (2007) · Diabetes · doi:10.2337/db07-0378 · Cited by 123
Mitochondrial density determines the cellular sensitivity to cisplatin-induced cell death
Qian, W., Nishikawa, M., Haque, A. M., Hirose, M., Mashimo, M., Sato, E. F., & Inoue, M. (2005) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00265.2005 · Cited by 133
Siddiq, A., Aminova, L. R., & Ratan, R. R. (2007) · Neurochemical Research · doi:10.1007/s11064-006-9268-7 · Cited by 129
Ni, Y., He, X., Chen, J., Moline, J., Mester, J. L., Orloff, M. S., Ringel, M. D., & Eng, C. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr459 · Cited by 126
Self-citationEnhanced Heme Function and Mitochondrial Respiration Promote the Progression of Lung Cancer Cells
Hooda, J., Cadinu, D., Alam, M. M., Shah, A. N., Cao, T., Sullivan, L. A., Brekken, R. A., & Li, Z. (2013) · PLoS ONE · doi:10.1371/journal.pone.0063402 · Cited by 127
Update on pediatric pheochromocytoma
Havekes, B., Romijn, J. A., Eisenhofer, G., Adams, K. T., & Pacák, K. (2008) · Pediatric Nephrology · doi:10.1007/s00467-008-0888-9 · Cited by 116
Eshaghian, A., Vleugels, R. A., Canter, J. A., Mcdonald, M., Stasko, T., & Sligh, J. E. (2005) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700088 · Cited by 115
On the association of succinate dehydrogenase mutations with hereditary paraganglioma
Baysal, B. E. (2003) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2003.08.004 · Cited by 106
Lande, Y., Fisch, B., Tsur, A., Farhi, J., Prag-Rosenberg, R., Ben‐Haroush, A., Kessler‐Icekson, G., Zahalka, M. A., Ludeman, S. M., & Abir, R. (2016) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2016.10.005 · Cited by 105
SDH-related pheochromocytoma and paraganglioma
Kantorovich, V., King, K. S., & Pacák, K. (2010) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2010.04.001 · Cited by 112
The role of HIF prolyl hydroxylases in tumour growth
Jokilehto, T., & Jaakkola, P. (2010) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2010.01030.x · Cited by 116
The contribution of mitochondria to common disorders
Enns, G. M. (2003) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2003.08.009 · Cited by 112
Extra-adrenal and adrenal pheochromocytomas associated with a germline SDHC mutation
Pęczkowska, M., Cascón, A., Prejbisz, A., Kubaszek, A., Ćwikła, J. B., Furmanek, M. I., Erlic, Z., Eng, C., Januszewicz, A., & Neumann, H. P. H. (2008) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet0726 · Cited by 108
Self-citationIntragenic Mutations in Thyroid Cancer
Sobrinho-Simões, M. A., Máximo, V., Rocha, A. S., Trovisco, V., Castro, P., Preto, A., Lima, J. P., & Soares, P. (2008) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2008.02.004 · Cited by 101
Pollard, P., Wortham, N., Barclay, E., Alam, A., Elia, G., Manek, S., Poulsom, R., & Tomlinson, I. (2005) · The Journal of Pathology · doi:10.1002/path.1686 · Cited by 100
Reyes, C., Karamurzin, Y. S., Frizzell, N., Garg, K., Nonaka, D., Chen, Y., & Soslow, R. A. (2013) · Modern Pathology · doi:10.1038/modpathol.2013.215 · Cited by 100
Weber, F., Shen, L., Fukino, K., Patócs, A., Mutter, G. L., Caldés, T., & Eng, C. (2006) · The American Journal of Human Genetics · doi:10.1086/504090 · Cited by 96
Self-citationAerobic glycolysis: a novel target in kidney cancer
Shuch, B. M., Linehan, W. M., & Srinivasan, R. (2013) · Expert Review of Anticancer Therapy · doi:10.1586/era.13.57 · Cited by 99
Petrillo, S. K., Desmeules, P., Truong, T., & Devine, P. J. (2011) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2011.03.012 · Cited by 96
Douwes Dekker, P., Hogendoorn, P., Kuipers‐Dijkshoorn, N., Prins, F., van Duinen, S., Taschner, P., van der Mey, A., & Cornelisse, C. (2003) · The Journal of Pathology · doi:10.1002/path.1461 · Cited by 94
Proteomic analysis of cancer-cell mitochondria
Verma, M., Kagan, J., Sidransky, D., & Srivastava, S. (2003) · Nature reviews. Cancer · doi:10.1038/nrc1192 · Cited by 94
Hereditary Paraganglioma/Pheochromocytoma and Inherited Succinate Dehydrogenase Deficiency
Favier, J., Brière, J.-J., Strompf, L., Amar, L., Filali, M., Jeunemaître, X., Rustin, P., & Gimenez‐Roqueplo, A. (2005) · Hormone Research in Paediatrics · doi:10.1159/000084685 · Cited by 105
Mitochondrial fumarate reductase as a target of chemotherapy: From parasites to cancer cells
Sakai, C., Tomitsuka, E., Esumi, H., Harada, S., & Kita, K. (2011) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2011.12.013 · Cited by 92
Hervouet, É. (2004) · Carcinogenesis · doi:10.1093/carcin/bgi001 · Cited by 91
McWhinney, S. R., Pilarski, R. T., Forrester, S. R., Schneider, M. C., Sarquis, M. M., Dias, E. P., & Eng, C. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0769 · Cited by 89
Self-citationMapping Gene Associations in Human Mitochondria using Clinical Disease Phenotypes
Scharfe, C., Lu, H. H., Neuenburg, J. K., Allen, E. A., Li, G.-C., Klopstock, T., Cowan, T. M., Enns, G. M., & Davis, R. W. (2009) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1000374 · Cited by 95
Mitochondrial dysfunction and cancer metastasis
Chen, E. I. (2012) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-012-9465-9 · Cited by 88
Paraganglioma, neuroblastoma, and a SDHB mutation: Resolution of a 30‐year‐old mystery
Schimke, R. N., Collins, D. L., & Stolle, C. A. (2010) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.33384 · Cited by 90
Genetic heterogeneity among uterine leiomyomata: insights into malignant progression
Hodge, J. C., & Morton, C. C. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm043 · Cited by 83
Mutations in the Isocitrate Dehydrogenase Genes IDH1 and IDH2 in Tumors
Schaap, F. G., French, P. J., & Bovée, J. V. M. G. (2012) · Advances in Anatomic Pathology · doi:10.1097/pap.0b013e31827b654d · Cited by 84
de Groof, A. J. C., Lindert, M. T., van Dommelen, M. M. T., Wu, M., Willemse, M. P., Smift, A., Winer, M., Oerlemans, F. T. J. J., Pluk, H., Fransen, J. A. M., et al. (2009) · Molecular Cancer · doi:10.1186/1476-4598-8-54 · Cited by 87
Metadata
- Authors
- Eng, C., Kiuru, M., Fernandez, M. J., & Aaltonen, L. A.
- Affiliations
- University of Cambridge (GB)
- The Ohio State University (US)
- Corresponding author
- Eng, Charis
- Venue
- Nature Reviews Cancer
- Published
- 2003-03
- Volume
- 3
- Issue
- 3
- Pages
- 193-202
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W1974567967
- Cited by
- 392
- References
- 64
- Citations by year
- 2026: 2 · 2025: 5 · 2024: 8 · 2023: 10 · 2022: 14 · 2021: 10 · 2020: 9 · 2019: 8 · 2018: 9 · 2017: 7 · 2016: 10 · 2015: 12 · 2014: 11 · 2013: 15 · 2012: 24
- FWCI
- 2.94
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Cancer (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
- Keywords
- mitochondrial enzymes, succinate dehydrogenase, fumarate hydratase, hereditary cancer, hereditary cancer predisposition, TCA cycle, mitochondrial dysfunction, neurological disorders, carcinogenesis, heterozygous mutation, homozygous mutation
- MeSH terms
- Carcinoma, Renal Cell, Citric Acid Cycle, Energy Metabolism, Forecasting, Free Radicals, Fumarate Hydratase, Heterozygote, Homozygote, Humans, Kidney Neoplasms, Mitochondria, Multienzyme Complexes, Mutation, Neoplastic Syndromes, Hereditary, Oxidoreductases, Paraganglioma, Pheochromocytoma, Succinate Dehydrogenase, Apoptosis, Mitochondrial Encephalomyopathies, Leiomyomatosis, Neovascularization, Physiologic, Protein Subunits, Electron Transport Complex II
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.